Medtronic Announces Planned Closure of Santa Rosa, California Facility After Nearly Three Decades of Operations

Medtronic recently announced plans for the next two yearsInternally closing its facility in CaliforniaSanta RosaThe factory, a move that will affect 370 local employees, marks the official end of the company's nearly three-decade operation in Sonoma County.

Medtronic has informed employees that some positions will begin to be relocated starting in the spring of 2027, with the plant expected to fully close by the spring of 2028. The affected employees includeFangting Grove ParkAll personnel, as well as those related toSanta RosaOperation-related remote or hybrid positions.

A Medtronic spokesperson said,Santa RosaThe business will mainly relocate to Santa Ana, California, Minnesota, and Galway, Ireland.

"Difficult but Strategic Decision"

Medtronic described this closure as a "difficult but strategic decision" made after a global operational review, with the aim of ensuring the company's long-term growth and meeting the evolving needs of patients and healthcare providers. In its statement, the company said, "We are deeply proud of the contributions made by our Santa Rosa employees, which have advanced our mission, strengthened patient care, and had a positive impact on the community." The company emphasized that customers will not be directly affected by this adjustment.

Starting from acquisitions, gradually scaling down

Medtronic entered the market in 1998 by acquiring Arterial Vascular Engineering (abbreviated as AVE) for $3.7 billion.Santa RosaAVE was once the world's largest manufacturer of heart stents. At its peak, Medtronic employed about 1,200 people locally in China.

However, Medtronic inSanta RosaThe scale has continued to shrink in recent years. In 2004, the company planned to cut the local workforce by half, but later increased investment due to growing demand for stents. In 2019, Medtronic began the first round of substantive layoffs, transferring some production to Danvers, Massachusetts, and cutting about 100 jobs. Three years ago,Santa RosaThe operation has been integrated into the Fountain Grove campus. Last year, Sonoma County purchased two Brickway Avenue office buildings previously used by Medtronic for $32 million.

A Broader Restructuring

This timeSanta RosaThe closure of the factory is part of a new round of major restructuring by Medtronic. The company has spun off its MiniMed diabetes business, which recently laid off more than 80 people in California. At the same time, Medtronic also announced the merger of its cardiac surgery and aortic businesses into a cardiovascular surgery division, and the consolidation of its structural heart, coronary, and renal denervation businesses to form an interventional cardiology therapies division. Medtronic stated that these adjustments aim to "accelerate the pace of innovation and increase investment in key areas."

Impact on the Local Economy

Santa RosaThe closure of the factory is another blow to the biotech industry in North Bay. An analyst from the Sonoma County Economic Development Partnership said, "Medtronic has always been an important part of the advanced manufacturing tradition in Sonoma County." According to statistics, about 5,000 people in the county work for companies that use high-tech systems for production.

For the affected employees, Medtronic stated that it will initiate a transition process to redeploy local employees "where feasible" and provide opportunities for remote work or transfer based on job roles and business needs. The company said that announcing the plan two years in advance is precisely to give employees more time.